Canada · Venture startup

Who invested in CELLFOR

3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$62Mraised across 3 rounds since 2005, from 3 sources

$32MSeries C$5.6MVenture$25MVenture
Latest round
Venture, $25MNov 2007
Biggest round
$32MSeries C · Oct 2005
Step-upi
4.4×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20062007
$32MSeries C$5.6MVenture$25MVenture
First round
Series C, $32M
Oct 2005
Biggest round
$32M
Series C · Oct 2005
Usual gap between rounds
13 months
the median of 2

The rounds

  1. Nov 2007
  2. Oct 2006
    Venture$5.6M1 new3 returning

    From a historical funding record

  3. Oct 2005

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

BDC CapitalVC firm3rounds
GrowthWorksVC firm3rounds
ATP CapitalVenture studio3rounds
Credit SuisseVC firm2rounds
Credit Suisse First BostonInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about CELLFOR

Who invested in CELLFOR?

CELLFOR's investors include BDC Capital, GrowthWorks, ATP Capital, Credit Suisse and Credit Suisse First Boston.

How much has CELLFOR raised?

CELLFOR has raised $62M across 3 rounds since 2005.

When did CELLFOR last raise?

CELLFOR's most recent round was a Venture of $25M in Nov 2007.

What was CELLFOR's biggest round?

CELLFOR's largest round on record is $32M (Series C), in Oct 2005.

Who backed CELLFOR first?

CELLFOR's first round on record, in Oct 2005, was backed by BDC Capital, GrowthWorks and Credit Suisse and 1 others.

What stage is CELLFOR at?

CELLFOR's latest named round is a Venture, in Nov 2007.

Where is CELLFOR based?

CELLFOR is based in Canada.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.